| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6843
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-062 |
| filingDate |
2016-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbed67562f30a2d081a26772f360ab82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89b8fea71f9f474816dd8b5108ddd930
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49409e38dea13f9d4cdcce4b47fc0e71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ce017d15adcecbedc8e23245c7724d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf27ca75918bbd7cb97f4c8e9818c77b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c34f278fabd38d51c5903f69b0194d3 |
| publicationDate |
2017-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170102980-A |
| titleOfInvention |
Benzodiazepine dimer, conjugates thereof, and methods of making and using |
| abstract |
A benzodiazepine dimer having a structure represented by: The variables in formulas (I), (Ia) and (Ib) are as defined in the present application. Such dimers are particularly useful as anticancer agents when used in antibody-drug conjugates (ADCs). |
| priorityDate |
2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |